Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-c... 26/11/2024 Industrial biotechnology Financing Financing led by TCGX, including new investment from TPG, Orbimed Advisors, Venrock Healthcare Capital Partners... Partners
Tebrio secures €30 million in funding from Banco de Santander, Sodical, GPC and CDTI 19/11/2024 Industrial biotechnology Financing The company, based in Salamanca, expects to triple its workforce in the next two years. This is when the construction of... Partners
ORYZON reports financial results and corporate update for quarter ended September 30, 2024 28/10/2024 Healthcare Advanced therapies Financing Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP annual conference in... Partners - Oryzon Genomics
"ABLE Human Motion was created almost 6 years ago with the vision of democratising robot... 24/10/2024 Healthcare Access to innovation Personalized medicine Financing Talento Corporate Partners - GENESIS Biomed
The public ecosystem of the Barcelona Science Park raises 70 million euros in 2023, 40% m... 24/10/2024 Healthcare Access to innovation Industrial biotechnology International Financing Talento These data consolidate the Barcelona Science Park as one of the most powerful hubs for public innovation in health in... Partners - Parc Científic de Barcelona
Asabys Announces the Closing of €180M Oversubscribed Sabadell Asabys II Fund 01/10/2024 Healthcare Financing Digitalization Similar to Sabadell Asabys Fund I, the Fund II portfolio will include companies within the fields of biopharma, medtech... Partners - Asabys Partners
Simbionte joins Lanzadera to become the go-to solution for Biotech SMEs looking to boost t... 30/09/2024 International EU projects Financing Talento Simbionte has been selected to join Lanzadera, one of the leading acceleration programs in Europe. This opportunity will... Partners - SIMBIONTE
Cash Need and Valuation: two key elements for a successful Investment Round 30/09/2024 Financing Before carrying out any investment round, it is essential to first quantify the start-up/spin-off's need for cash. Partners - GENESIS Biomed
